search
Back to results

The Metabolic Effects of Almond Consumption in Adults With Pre-Diabetes

Primary Purpose

Prediabetes, Insulin Resistance, Metabolic Syndrome

Status
Completed
Phase
Phase 1
Locations
United States
Study Type
Interventional
Intervention
Almonds in a calorie controlled diet
Nut free diet
Sponsored by
University of Medicine and Dentistry of New Jersey
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Prediabetes focused on measuring almonds, pre-diabetes, inflammatory, CRP

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Age greater than 18 years No self-reported allergy to almonds No history of irritable bowel disease or diverticulitis that could be exacerbated by daily almond intake Presence of pre-diabetes according to the 2005 American Diabetes Association diagnostic guidelines (fasting blood glucose between 100 to 125 mg/dl or casual blood glucose ≥ 140-199 mg/dl) Body mass index (BMI) 20-35 kg/m2 to enhance the generalizability of the study's findings to the population of adults with pre-diabetes Willingness to discontinue vitamin E supplement usage while enrolled in the study. Exclusion Criteria: No concurrent use of corticosteroids or immunosuppressant medications (tacrolimus, cyclosporine, sirolimus, azathioprine, 6-mercaptopurine, mycophenolate mofetil, everolimus) in light of their effect on inflammatory biomarkers No liver disease, renal disease and/or severe dyslipidemia (triglycerides [TG] > 400mg/dl or total cholesterol [TC] > 300 mg/dl)

Sites / Locations

  • UMDNJ

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

nut free diet

almond group

Arm Description

ADA recommended diabetes diet without any nuts

calorie controlled diet with prescribed daily amount of almonds

Outcomes

Primary Outcome Measures

HbA1c
change in HbA1c over the course of 16 wk intervention as an indication of blood glucose control

Secondary Outcome Measures

hs-CRP
change in high sensitivity C Reactive Protein as an indication of inflammation over course of the intervention
Il-6
Change in Interleukin 6 over the 16 week intervention as an indication of inflammation/metabolic syndrome

Full Information

First Posted
December 27, 2005
Last Updated
June 20, 2016
Sponsor
University of Medicine and Dentistry of New Jersey
Collaborators
Almond Board of California
search

1. Study Identification

Unique Protocol Identification Number
NCT00270985
Brief Title
The Metabolic Effects of Almond Consumption in Adults With Pre-Diabetes
Official Title
The Metabolic Effects of Almond Consumption in Adults With Pre-Diabetes
Study Type
Interventional

2. Study Status

Record Verification Date
June 2016
Overall Recruitment Status
Completed
Study Start Date
January 2006 (undefined)
Primary Completion Date
May 2007 (Actual)
Study Completion Date
June 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Medicine and Dentistry of New Jersey
Collaborators
Almond Board of California

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Study Hypothesis: Daily consumption of almonds over 16 weeks will produce a decrease in hemoglobin A1c (HbA1c) levels in adults with pre-diabetes. Lay Summary: Persons developing type 2 diabetes mellitus (T2DM) will typically first have a condition called pre-diabetes. Lifestyle is a major factor that determines whether pre-diabetes becomes full T2DM. Lifestyle includes dietary habits and physical activity. Many people develop T2DM because of poor dietary habits and a sedentary lifestyle. Moreover, eating a high-fat, high-sugar diet can damage the blood vessels and increase the risk of strokes and heart attacks. A person's diet may produce substances in the blood that can interfere with the production of insulin in the pancreas. Sometimes, these changes in the insulin producing cells are serious and can eventually interfere with how the cells in the body use blood sugar, which causes T2DM. Techniques are available to measure circulating substances in the blood of persons with pre-diabetes that may be associated with the development of T2DM. Laboratory research has shown that almonds contain high levels of important compounds that may influence the onset of heart disease and T2DM. A meal plan that includes almonds daily will be given to half of the study participants and the other participants will be given a meal plan that is "nut-free". Because of the potential to delay the onset of heart disease and T2DM in some persons with pre-diabetes, this 16-week study will collect and analyze blood samples for changes that may make the person with pre-diabetes more likely to develop heart disease and T2DM. Blood samples will be collected at weeks 0, 8 and 16 to measure compounds that may be influenced by consuming almonds daily. This study will also attempt to understand other possible causes of heart disease and T2DM in persons with pre-diabetes; particularly those that might be related to body weight and body composition. Body composition techniques using very small amounts of electrical current are available to study body fat. Body weight, waist and hip measurements, blood pressure and body composition testing will be performed at the start of the study and every 4 weeks during the study. Lastly, these other possible causes of heart disease and T2DM will be investigated to look at relationships with the substances in the blood.
Detailed Description
Daily consumption of almonds over 16 weeks will produce a decrease in hemoglobin A1c (HbA1c) levels in adults with pre-diabetes. Lay Summary: Persons developing type 2 diabetes mellitus (T2DM) will typically first have a condition called pre-diabetes. Lifestyle is a major factor that determines whether pre-diabetes becomes full T2DM. Lifestyle includes dietary habits and physical activity. Many people develop T2DM because of poor dietary habits and a sedentary lifestyle. Moreover, eating a high-fat, high-sugar diet can damage the blood vessels and increase the risk of strokes and heart attacks. A person's diet may produce substances in the blood that can interfere with the production of insulin in the pancreas. Sometimes, these changes in the insulin producing cells are serious and can eventually interfere with how the cells in the body use blood sugar, which causes T2DM. Techniques are available to measure circulating substances in the blood of persons with pre-diabetes that may be associated with the development of T2DM. Laboratory research has shown that almonds contain high levels of important compounds that may influence the onset of heart disease and T2DM. A meal plan that includes almonds daily will be given to half of the study participants and the other participants will be given a meal plan that is "nut-free". Because of the potential to delay the onset of heart disease and T2DM in some persons with pre-diabetes, this 16-week study will collect and analyze blood samples for changes that may make the person with pre-diabetes more likely to develop heart disease and T2DM. Blood samples will be collected at weeks 0, 8 and 16 to measure compounds that may be influenced by consuming almonds daily. This study will also attempt to understand other possible causes of heart disease and T2DM in persons with pre-diabetes; particularly those that might be related to body weight and body composition. Body composition techniques using very small amounts of electrical current are available to study body fat. Body weight, waist and hip measurements, blood pressure and body composition testing will be performed at the start of the study and every 4 weeks during the study. Lastly, these other possible causes of heart disease and T2DM will be investigated to look at relationships with the substances in the blood.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Prediabetes, Insulin Resistance, Metabolic Syndrome
Keywords
almonds, pre-diabetes, inflammatory, CRP

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 1
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
66 (Actual)

8. Arms, Groups, and Interventions

Arm Title
nut free diet
Arm Type
Active Comparator
Arm Description
ADA recommended diabetes diet without any nuts
Arm Title
almond group
Arm Type
Experimental
Arm Description
calorie controlled diet with prescribed daily amount of almonds
Intervention Type
Behavioral
Intervention Name(s)
Almonds in a calorie controlled diet
Intervention Description
Prescribed daily dose of Almonds in calorie controlled diet for adults with pre-type 2 diabetes
Intervention Type
Behavioral
Intervention Name(s)
Nut free diet
Intervention Description
Calorie controlled diet free of nuts for adults with pre-type 2 diabetes
Primary Outcome Measure Information:
Title
HbA1c
Description
change in HbA1c over the course of 16 wk intervention as an indication of blood glucose control
Time Frame
16 weeks
Secondary Outcome Measure Information:
Title
hs-CRP
Description
change in high sensitivity C Reactive Protein as an indication of inflammation over course of the intervention
Time Frame
16 wks
Title
Il-6
Description
Change in Interleukin 6 over the 16 week intervention as an indication of inflammation/metabolic syndrome
Time Frame
16 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age greater than 18 years No self-reported allergy to almonds No history of irritable bowel disease or diverticulitis that could be exacerbated by daily almond intake Presence of pre-diabetes according to the 2005 American Diabetes Association diagnostic guidelines (fasting blood glucose between 100 to 125 mg/dl or casual blood glucose ≥ 140-199 mg/dl) Body mass index (BMI) 20-35 kg/m2 to enhance the generalizability of the study's findings to the population of adults with pre-diabetes Willingness to discontinue vitamin E supplement usage while enrolled in the study. Exclusion Criteria: No concurrent use of corticosteroids or immunosuppressant medications (tacrolimus, cyclosporine, sirolimus, azathioprine, 6-mercaptopurine, mycophenolate mofetil, everolimus) in light of their effect on inflammatory biomarkers No liver disease, renal disease and/or severe dyslipidemia (triglycerides [TG] > 400mg/dl or total cholesterol [TC] > 300 mg/dl)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Susan E Gould Fogerite, PhD
Organizational Affiliation
Rutgers, The State University of New Jersey
Official's Role
Principal Investigator
Facility Information:
Facility Name
UMDNJ
City
Newark
State/Province
New Jersey
ZIP/Postal Code
07103
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
No plan to make individual participant data (IPD) available.
Citations:
PubMed Identifier
20833991
Citation
Wien M, Bleich D, Raghuwanshi M, Gould-Forgerite S, Gomes J, Monahan-Couch L, Oda K. Almond consumption and cardiovascular risk factors in adults with prediabetes. J Am Coll Nutr. 2010 Jun;29(3):189-97. doi: 10.1080/07315724.2010.10719833.
Results Reference
result

Learn more about this trial

The Metabolic Effects of Almond Consumption in Adults With Pre-Diabetes

We'll reach out to this number within 24 hrs